ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

40,086Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 551

$1.15M Total Retail Price of All Prescriptions

Rank: 9 out of 551

935 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 935 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

3% of this provider’s 935 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 29,026 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 3,150 2,205 1 1
METFORMIN HCL 1,545 1,095 2 2
GABAPENTIN 1,505 1,054 3 3
AMLODIPINE BESYLATE 1,411 1,132 4 4
SYNTHROID 1,366 901 5 11
ENALAPRIL MALEATE 1,291 954 10 6 5
RANITIDINE HCL 1,283 1,006 7 8
OMEPRAZOLE 953 625 8 7
LOSARTAN-HYDROCHLOROTHIAZIDE 889 698 9 10
PENTOXIFYLLINE 872 663 10 10 73
LOSARTAN POTASSIUM 840 612 11 6
GLIPIZIDE 808 645 10 12 20
ALENDRONATE SODIUM 766 601 13 19
METOPROLOL TARTRATE 721 505 14 17
FUROSEMIDE 645 513 15 13
ZOLPIDEM TARTRATE 561 410 16 27
LISINOPRIL 544 306 17 14
ISOSORBIDE MONONITRATE ER 542 476 18 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 492 338 19 59
METOPROLOL SUCCINATE 485 373 20 23
ASPIRIN EC 474 393 21 26
AMITRIPTYLINE HCL 471 347 R 22 96
LEVOTHYROXINE SODIUM 462 337 23 9
FAMOTIDINE 460 305 24 31
DOXAZOSIN MESYLATE 443 376 25 25
CARVEDILOL 438 359 26 22
HYDROCHLOROTHIAZIDE 435 345 27 15
LEVOXYL 420 330 28 40
SULINDAC 332 257 10 29 78
INSULIN SYRINGE 325 225 30 41
HUMULIN 70-30 295 218 31 35
TRAMADOL HCL-ACETAMINOPHEN 293 199 32 18
CIPROFLOXACIN HCL 282 200 33 54
DICLOFENAC POTASSIUM 262 169 34 45
AZITHROMYCIN 246 150 35 55
CLOPIDOGREL 244 191 36 30
VERAPAMIL ER 238 195 37 39
HUMALOG MIX 75-25 224 151 38 110
PLAVIX 217 178 39 33
SERTRALINE HCL 211 172 40 43
ACTOS 211 131 40 135
CLOTRIMAZOLE-BETAMETHASONE 208 146 42 49
SURE COMFORT 205 169 43 74
ASPIR-LOW 203 167 44 141
TAMSULOSIN HCL 199 191 45 38
DICLOFENAC SODIUM 195 131 46 99
LANTUS 194 133 47 28
IRBESARTAN 183 111 48 51
FINASTERIDE 178 150 49 82
FISH OIL OMEGA-3 175 127 10 50 253
DIGOXIN 174 150 51 44
FENOFIBRATE 172 111 52 34
TRAMADOL HCL 171 104 53 32
AMOX TR-POTASSIUM CLAVULANATE 163 99 54 113
MECLIZINE HCL 158 152 55 56
FLUOXETINE HCL 156 110 56 93
VITAMIN B-12 154 108 57 149
DILTIAZEM HCL 154 112 57 106
GLIMEPIRIDE 153 93 59 16
SUCRALFATE 148 108 60 120
VITAMIN E 143 78 10 61 270
ENDOCET 140 56 S2 62 157
BISOPROLOL-HYDROCHLOROTHIAZIDE 138 66 63 112
AVAPRO 134 85 64 83
PRAVASTATIN SODIUM 130 86 65 24
WARFARIN SODIUM 130 110 65 46
AVELOX 128 88 67 148
CALTRATE 600 + D 125 95 10 68 144
CRESTOR 123 79 69 62
PREDNISONE 114 54 70 65
DIPYRIDAMOLE 114 91 R 70 76
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 75 72 119
COUMADIN 105 90 73 88
DIOVAN HCT 104 84 74 71
PIROXICAM 103 57 75 178
METOCLOPRAMIDE HCL 102 69 76 107
NIFEDIPINE ER 102 57 76 75
ORPHENADRINE CITRATE 98 12 R 78 147
NABUMETONE 97 60 79 37
AMLODIPINE BESYLATE-BENAZEPRIL 97 68 79 42
AMIODARONE HCL 95 92 81 189
PREMARIN 94 26 R 82 234
CIMETIDINE 94 59 82 193
SPIRONOLACTONE 90 77 84 79
DOCUSATE CALCIUM 87 75 10 85 299
METOLAZONE 87 70 85 142
CYMBALTA 86 45 87 105
NAPROXEN 83 49 88 80
HUMALOG 82 43 89 101
VITAMIN D3 79 57 10 90 219
MUPIROCIN 79 48 90 185
LYRICA 78 73 92 86
VYTORIN 76 42 93 132
NEOMYCIN-POLYMYXIN-DEXAMETH 76 52 93 262
QUETIAPINE FUMARATE 76 59 93 171
SINGULAIR 73 45 96 58
IOPHEN DM-NR 70 52 10 97 321
PRAMIPEXOLE DIHYDROCHLORIDE 69 62 98 196
DONEPEZIL HCL 68 61 99 50
PROPRANOLOL HCL 68 25 99 139
ECONAZOLE NITRATE 65 42 101 236
GLYBURIDE-METFORMIN HCL 63 58 R 102 48
CETIRIZINE HCL 62 45 103 154
ATORVASTATIN CALCIUM 60 43 104 29
GEMFIBROZIL 59 44 105 61
ACETAMINOPHEN-CODEINE 58 38 S3 106 276
GLYBURIDE MICRONIZED 58 49 R 106 91
CALCIUM 600 + VIT D 57 43 108 209
DIOVAN 57 42 108 57
SPIRIVA 57 50 108 133
ATENOLOL 53 32 111 12
OMEGA-3 53 37 111 269
CLOBETASOL PROPIONATE 51 30 113 177
CLONIDINE HCL 50 34 114 60
TIMOLOL MALEATE 50 50 114 214
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.